Penobscot Investment Management Company, Inc. - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 77 filers reported holding UTAH MED PRODS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Penobscot Investment Management Company, Inc. ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$344,000
-7.7%
4,0000.0%0.05%
-23.0%
Q2 2023$372,800
-1.7%
4,0000.0%0.06%
-7.6%
Q1 2023$379,080
-5.7%
4,0000.0%0.07%
-7.0%
Q4 2022$402,120
+17.9%
4,0000.0%0.07%
+10.9%
Q3 2022$341,000
-0.9%
4,0000.0%0.06%
+8.5%
Q2 2022$344,000
-4.2%
4,0000.0%0.06%
+13.5%
Q1 2022$359,000
-10.2%
4,0000.0%0.05%
-3.7%
Q4 2021$400,000
+7.8%
4,0000.0%0.05%
-1.8%
Q3 2021$371,000
+9.1%
4,0000.0%0.06%
+10.0%
Q2 2021$340,000
-1.7%
4,0000.0%0.05%
-9.1%
Q1 2021$346,000
+2.7%
4,0000.0%0.06%
-1.8%
Q4 2020$337,000
+5.6%
4,0000.0%0.06%
-6.7%
Q3 2020$319,000
-9.9%
4,0000.0%0.06%
-17.8%
Q2 2020$354,000
-5.9%
4,0000.0%0.07%
-17.0%
Q1 2020$376,000
-13.0%
4,0000.0%0.09%
+8.6%
Q4 2019$432,000
+12.8%
4,0000.0%0.08%
+6.6%
Q3 2019$383,0000.0%4,0000.0%0.08%
-2.6%
Q2 2019$383,000
+8.5%
4,0000.0%0.08%
+4.0%
Q1 2019$353,000
+6.3%
4,0000.0%0.08%
-6.2%
Q4 2018$332,000
-11.9%
4,0000.0%0.08%
-1.2%
Q3 2018$377,000
-14.5%
4,0000.0%0.08%
-21.4%
Q2 2018$441,000
+11.6%
4,0000.0%0.10%
+8.4%
Q1 2018$395,000
+21.2%
4,0000.0%0.10%
+5.6%
Q4 2017$326,000
+10.9%
4,0000.0%0.09%
+2.3%
Q3 2017$294,000
+1.4%
4,0000.0%0.09%
-5.4%
Q2 2017$290,000
+16.5%
4,0000.0%0.09%
+12.0%
Q1 2017$249,000
-14.4%
4,0000.0%0.08%
-17.8%
Q4 2016$291,000
+21.8%
4,0000.0%0.10%
+20.2%
Q3 2016$239,000
-5.2%
4,0000.0%0.08%
-6.7%
Q2 2016$252,000
+0.8%
4,0000.0%0.09%
-4.3%
Q1 2016$250,000
+6.8%
4,0000.0%0.09%
+28.8%
Q4 2015$234,000
+8.8%
4,0000.0%0.07%
+1.4%
Q3 2015$215,000
-10.0%
4,0000.0%0.07%
-2.7%
Q2 2015$239,000
-20.1%
4,000
-20.0%
0.07%
-22.1%
Q1 2015$299,000
-16.9%
5,000
-16.7%
0.10%
-15.9%
Q4 2014$360,000
-0.3%
6,000
-18.9%
0.11%
-5.8%
Q3 2014$361,000
-5.2%
7,4000.0%0.12%
-6.2%
Q2 2014$381,000
-11.0%
7,4000.0%0.13%
-15.8%
Q1 2014$428,000
+1.2%
7,4000.0%0.15%
+1.3%
Q4 2013$423,000
-3.9%
7,4000.0%0.15%
-13.3%
Q3 2013$440,000
+9.5%
7,4000.0%0.17%
+3.0%
Q2 2013$402,0007,4000.17%
Other shareholders
UTAH MED PRODS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Penn Mutual Asset Management, LLC 30,283$2,822,3762.54%
Clean Yield Group 30,703$2,861,5201.18%
RICE HALL JAMES & ASSOCIATES, LLC 112,999$10,531,4680.60%
Ranger Investment Management 78,681$7,333,0690.44%
Watershed Asset Management, L.L.C. 2,515$234,3980.29%
ISTHMUS PARTNERS, LLC 20,937$1,951,3280.27%
Cardinal Capital Management 11,309$1,057,3250.21%
GLOBEFLEX CAPITAL L P 9,338$870,3020.10%
Penobscot Investment Management Company, Inc. 4,000$372,8000.06%
JAMES INVESTMENT RESEARCH INC 4,292$400,0140.05%
View complete list of UTAH MED PRODS INC shareholders